FLUPHENAZINE HYDROCHLORIDE
NDC 10135-726, FLUPHENAZINE HYDROCHLORIDE, tablet, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-726
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214674
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-726 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUPHENAZINE HYDROCHLORIDE2.5 mg/1
Pharmacologic classes
Phenothiazine [EPC]; Phenothiazines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-726-01 | 10135072601 | 100 TABLET in 1 BOTTLE (10135-726-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c69f07b1-660c-db03-e053-2995a90a5464
Use it
Look up 10135-726 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-726 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-726. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.